Social interactions can influence how physicians recommend breast cancer screenings

Perhaps rules are meant to be broken. But guidelines, according to recent research, are not always followed when physicians recommend breast cancer screening to patients.

A research letter published Dec. 4 in JAMA: Internal Medicine, explores how social interactions with friends, family and colleagues who have been diagnosed with breast cancer may affect a physician’s recommendations to patients.

Led by Craig Evan Pollack, MD, MHS, with Johns Hopkins University in Baltimore, a group of researchers surveyed 848 physicians who had a social network member diagnosed with breast cancer. Some 44.7 percent were general practitioners or specialized in family medicine, with 29 percent in internal medicine and 26.3 in gynecology. These physicians reported 1,631 social network members receiving breast cancer diagnoses, including 771 patients and 381 family members.

Physicians familiar with someone with a poor prognosis who was not diagnosed via screening were much more likely to recommend routine checks for women between 40 and 44 years old and those over 75.

“Describing a woman whose breast cancer was not diagnosed by screening mammogram and who had a poor prognosis was associated with increased odds of recommending routine screening to patients within the designated younger and older age groups for which guidelines no longer support routine, universal screening,” Pollack et al. wrote. “Our results suggest that helping clinicians reflect on how their experiences influence their current screening patterns may be an important approach to improve adherence to revised breast cancer screening guidelines.”

The researchers noted how bad experiences are recalled more frequently than positive ones, which can lead physicians to perceive a greater risk than those not familiar with dreaded outcomes.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup